51 filings
8-K
NKGN
NKGen Biotech Inc
13 May 24
Entry into a Material Definitive Agreement
8:05am
8-K
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
NKGN
NKGen Biotech Inc
29 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
NKGN
NKGen Biotech Inc
24 Apr 24
Entry into a Material Definitive Agreement
7:51pm
8-K
NKGN
NKGen Biotech Inc
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
43eqvgv
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
dy0wm2qwfe2y m6h2s
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
x3z4vrk
20 Mar 24
Other Events
4:01pm
8-K
injg2rp
15 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:02pm
8-K
qqd ovmnwuno
22 Feb 24
Entry into a Material Definitive Agreement
4:01pm
8-K
bd726z cq
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:00pm
8-K
3m6h41q8
12 Feb 24
Entry into a Material Definitive Agreement
9:25am
8-K
uv4ytmsuy6jcy
8 Feb 24
Departure of Directors or Certain Officers
5:07pm
8-K
dwl1emjdsr2c0
22 Jan 24
Entry into a Material Definitive Agreement
6:12am
8-K
ifzcpq2hgd9s
11 Jan 24
Entry into a Material Definitive Agreement
7:50pm
8-K
snc77cp6 c9koropp
8 Jan 24
Entry into a Material Definitive Agreement
5:19pm
8-K
r8ruyge w1d
28 Dec 23
Other Events
4:14pm
8-K
sbckwskmqc fg8h8wc9a
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm
8-K
3q6ritwb s0
27 Dec 23
Entry into a Material Definitive Agreement
4:01pm
8-K
i56ht o8njxnf
14 Nov 23
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
4:36pm